Masashi Kanai

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Cancer science

Cancer medicine

International journal of clinical oncology

BMC medical genomics

This page only lists publications with an associated author ORCID identifier.

Publications

Hitomi Sumiyoshi Okuma, Keisuke Watanabe, Kenji Tsuchihashi, Ryunosuke Machida, Ryo Sadachi, Akihiro Hirakawa, Hiroshi Ariyama, Masashi Kanai, Masahisa Kamikura, Kenta Anjo, Akari Hiramitsu, Shigeki Sekine, Natsuko Okita, Hiroyuki Mano, Hiroyoshi Nishikawa, Kenichi Nakamura, Kan Yonemori
Phase 2 trial of nivolumab in metastatic rare cancer with dMMR or MSI-H and relation with immune phenotypic analysis (the ROCK trial). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tomohiro Kondo, Masashi Kanai, Junichi Matsubara, Daisuke Yamaguchi, Takashi Ura, Tadayuki Kou, Toshinao Itani, Motoo Nomura, Taro Funakoshi, Akira Yokoyama, Keitaro Doi, Masashi Tamaoki, Michio Yoshimura, Norimitsu Uza, Takahiro Yamada, Toshihiko Masui, Sachiko Minamiguchi, Shigemi Matsumoto, Hideki Ishikawa, Manabu Muto
Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study. Medical oncology (Northwood, London, England) 40 (5) (2023)
Toshihiko Masui, Kazuyuki Nagai, Takayuki Anazawa, Yosuke Kasai, Akitada Yogo, Michio Yoshimura, Takashi Mizowaki, Norimitsu Uza, Akihisa Fukuda, Shigemi Matsumoto, Masashi Kanai, Hiroyoshi Isoda, Yoshiya Kawaguchi, Shinji Uemoto, Etsuro Hatano
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A prospective, open-label, phase II study. Cancer medicine (2023)
Masashi Kanai, Takahisa Kawaguchi, Masahito Kotaka, Dai Manaka, Junichi Hasegawa, Akinori Takagane, Yoshinori Munemoto, Takeshi Kato, Tetsuya Eto, Tetsuo Touyama, Takanori Matsui, Katsunori Shinozaki, Shigemi Matsumoto, Tsunekazu Mizushima, Masaki Mori, Junichi Sakamoto, Atsushi Ohtsu, Takayuki Yoshino, Shigetoyo Saji, Fumihiko Matsuda
Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population. Cancer medicine (2022)
Tomohiro Kondo, Yoshihiro Yamamoto, Keita Fukuyama, Masashi Kanai, Atsushi Yamada, Junichi Matsubara, Pham Nguyen Quy, Masahiro Yoshioka, Takahiro Yamada, Sachiko Minamiguchi, Shigemi Matsumoto, Shinji Kosugi, Manabu Muto
Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling. International journal of clinical oncology 27 (8) (2022)
Mitsuho Imai, Yoshiaki Nakamura, Kuniko Sunami, Hidenori Kage, Keigo Komine, Takafumi Koyama, Toraji Amano, Daisuke Ennishi, Masashi Kanai, Hirotsugu Kenmotsu, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Hideaki Bando, Akitaka Makiyama, Tatsuya Suzuki, Makoto Hirata, Shinji Kohsaka, Katsuya Tsuchihara, Yoichi Naito, Takayuki Yoshino
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors. Cancer science 113 (11) (2022)
Kuniko Sunami, Yoichi Naito, Keigo Komine, Toraji Amano, Daisuke Ennishi, Mitsuho Imai, Hidenori Kage, Masashi Kanai, Hirotsugu Kenmotsu, Takafumi Koyama, Takahiro Maeda, Sachi Morita, Daisuke Sakai, Shinji Kohsaka, Katsuya Tsuchihara, Yusuke Saigusa, Takayuki Yoshino
Chronological improvement in precision oncology implementation in Japan. Cancer science 113 (11) (2022)
Yoshihiro Yamamoto, Keita Fukuyama, Masashi Kanai, Tomohiro Kondo, Masahiro Yoshioka, Tadayuki Kou, Pham Nguyen Quy, Reiko Kimura-Tsuchiya, Takahiro Yamada, Shigemi Matsumoto, Shinji Kosugi, Manabu Muto
Prevalence of pathogenic germline variants in the circulating tumor DNA testing. International journal of clinical oncology 27 (10) (2022)
Pham Nguyen Quy, Keita Fukuyama, Masashi Kanai, Tadayuki Kou, Tomohiro Kondo, Masahiro Yoshioka, Junichi Matsubara, Tomohiro Sakuma, Sachiko Minamiguchi, Shigemi Matsumoto, Manabu Muto
Inter-assay variability of next-generation sequencing-based gene panels. BMC medical genomics 15 (1) (2022)
Hitomi Ozawa-Umeta, Atsuhiro Kishimoto, Atsushi Imaizumi, Tadashi Hashimoto, Tadashi Asakura, Hideaki Kakeya, Masashi Kanai
Curcumin β-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivo. Cancer science 111 (5) (2020)
Tomohiro Kondo, Junichi Matsubara, Pham Nguyen Quy, Keita Fukuyama, Motoo Nomura, Taro Funakoshi, Keitaro Doi, Yuichi Sakamori, Masahiro Yoshioka, Akira Yokoyama, Masashi Tamaoki, Tadayuki Kou, Kenshiro Hirohashi, Atsushi Yamada, Yoshihiro Yamamoto, Sachiko Minamiguchi, Masakazu Nishigaki, Takahiro Yamada, Masashi Kanai, Shigemi Matsumoto, Manabu Muto
Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer. Cancer science 112 (1) (2020)

Masashi Kanai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masashi Kanai